Taris Biomedical LLC:企業のM&A・事業提携・投資動向

◆英語タイトル:Taris Biomedical LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1992
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:105
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Taris Biomedical LLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Taris Biomedical LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Taris Biomedical LLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Taris Biomedical LLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Taris Biomedical LLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Taris Biomedical LLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Taris Biomedical LLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for Taris Biomedical LLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Taris Biomedical LLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
PARTNERSHIP 7
Partnership – Overview 7
Partnership – Deal reports 8
CAPITAL RAISING 40
Capital Raising – Overview 40
Capital Raising – Deal reports 41
PRIVATE EQUITY & OWNERSHIP 82
Private Equity and Ownership – Overview 82
Private Equity and Ownership – Deal reports 83
APPENDIX 95
Contact Us 95
About MarketLine Financial Deals Database 95
Deal Definition and Methodology 97
About MarketLine 104

List of Tables
Table 1: Taris Biomedical LLC partnership volume and value trend (2014-YTD2018)
Table 2: Taris Biomedical LLC partnership trend by key deal type (2014-YTD2018)
Table 3: Taris Biomedical LLC capital raising volume and value trend (2014-YTD2018)
Table 4: Taris Biomedical LLC capital raising by deal type (2014-YTD2018)
Table 5: Taris Biomedical LLC private equity and ownership volume and value trend (2014-YTD2018)
Table 6: Taris Biomedical LLC private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Taris Biomedical LLC partnership volume and value trend (2014-YTD2018)
Figure 2: Taris Biomedical LLC partnership trend by key deal type (2014-YTD2018)
Figure 3: Taris Biomedical LLC capital raising volume and value trend (2014-YTD2018)
Figure 4: Taris Biomedical LLC capital raising by deal type (2014-YTD2018)
Figure 5: Taris Biomedical LLC private equity and ownership volume and value trend (2014-YTD2018)
Figure 6: Taris Biomedical LLC private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Taris Biomedical LLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Continental Resources Inc (CLR):石油・ガス:M&Aディール及び事業提携情報
    Summary Continental Resources Inc (Continental Resources) is an oil and gas company involved in the distribution of fuel and related products and services. The company offerings include supply fulfillment and energy advisory services to commercial and industrial customers. It owns and operates Bakke …
  • Gamida Cell Ltd:企業のM&A・事業提携・投資動向
    Gamida Cell Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gamida Cell Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Motor Sich JSC:企業の戦略・SWOT・財務情報
    Motor Sich JSC - Strategy, SWOT and Corporate Finance Report Summary Motor Sich JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Cerebrotech Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cerebrotech Medical Systems Inc (Cerebrotech) is a medical device company focused on the development of neurotechnology solutions for non-invasive monitoring of patients after stroke or traumatic brain injury. The company’s Cerebrotech Visor is a portable non-invasive wireless neuro monitori …
  • Mundipharma International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mundipharma International Ltd (Mundipharma) engages in the research and development of products for the treatment pain management, respiratory, cancer and inflammatory conditions. The company commercializes and launches products within Europe and rest of the world. Mundipharma offers its pro …
  • Intas Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropo …
  • Dana Petroleum Ltd:企業の戦略的SWOT分析
    Dana Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Gladstone Capital Corp:企業のM&A・事業提携・投資動向
    Gladstone Capital Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gladstone Capital Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Singapore Power Ltd:企業の戦略的SWOT分析
    Singapore Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Elsalys Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The company's pipeline programs include anti-CD160, for macular degeneration or certain retinopathie …
  • XERIS Pharmaceuticals Inc (XERS):製薬・医療:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Sime Darby Berhad:企業の戦略・SWOT・財務情報
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biolife Solutions Inc (BLFS):企業の財務・戦略的SWOT分析
    Summary BioLife Solutions Inc (BioLife Solutions) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company offers serum-free and protein-free solutions, which are formulated to red …
  • Italian Coffee Holdings Ltd:企業の戦略・SWOT・財務分析
    Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • YKK Corporation:企業の戦略・SWOT・財務情報
    YKK Corporation - Strategy, SWOT and Corporate Finance Report Summary YKK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • transcosmos Inc:企業の戦略・SWOT・財務分析
    transcosmos Inc - Strategy, SWOT and Corporate Finance Report Summary transcosmos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CVRx Inc-医療機器分野:企業M&A・提携分析
    Summary CVRx Inc (CVRx) is a medical device company that develops and designs implantable device. The company offers barostim neo system, which is designed to trigger the body’s natural blood flow regulation system to treat high blood pressure and heart failure. Its products are used in the treatmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆